Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02446093
Title Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma (PaTK02)
Acronym PaTK02
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Candel Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lee Health/Regional Cancer Center Fort Myers Florida 33905 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Mexico City 14080 Mexico Details
*Shaded cells indicate that there was no data available from for the field